Literature DB >> 26497342

Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature.

Rodrigo Donalisio da Silva1, Luke Bidikov, Walker Michaels, Diedra Gustafson, Wilson R Molina, Fernando J Kim.   

Abstract

INTRODUCTION: For decades, the monopolar transurethral resection of the prostate has been established as the minimally invasive surgical treatment for patients with benign prostatic hyperplasia (BPH). In recent years, new technologies and devices emerged to reduce the morbidity and improve outcomes for this treatment approach. Bipolar energy introduced the use of saline irrigation and laser technology increased the urological armamentarium to treat BPH. We performed a systematic review of the literature regarding bipolar technology for the treatment of BPH.
MATERIALS AND METHODS: A MEDLINE database search using the PRISMA methodology. Selected literature was restricted to articles published in English and published between 2005 and 2015. Articles regarding techniques using bipolar energy were included, while manuscripts that used a different technique, hybrid techniques, or techniques other than bipolar resection, bipolar vaporization, and bipolar enucleation were excluded.
RESULTS: The use of bipolar energy in the endoscopic treatment of BPH presented a significant reduction in operative time, perioperative complications, shorter catheterization time, reduced number of blood products transfused, and shorter hospital stay compared to standard techniques. Postoperative outcomes showed that bipolar energy was safe and offered significant outcome improvement when compared to traditional monopolar transurethral resection of the prostate (TURP).
CONCLUSION: The use of bipolar energy in the surgical treatment of patients with BPH is safe and is associated with improvements in perioperative outcomes. Short and mid-term functional outcomes are comparable to standard techniques, but long term functional outcomes need better clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26497342

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  7 in total

1.  Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies.

Authors:  Chaohui Gu; Naichun Zhou; Pratik Gurung; Yiping Kou; Yang Luo; Yidi Wang; Hui Zhou; Cheng Zhen; Jinjian Yang; Fengyan Tian; Guan Wu
Journal:  World J Urol       Date:  2019-06-17       Impact factor: 4.226

2.  [Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation].

Authors:  M Rieken; A Bachmann; S F Shariat
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

3.  Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up.

Authors:  Zhonghua Yang; Tongzu Liu; Xinghuan Wang
Journal:  Lasers Med Sci       Date:  2016-09-27       Impact factor: 3.161

Review 4.  A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors.

Authors:  Yasser Osman; Ahmed M Harraz
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

5.  Comparison of Safety, Efficacy and Cost Effectiveness of Photoselective Vaporization with Bipolar Vaporization of Prostate in Benign Prostatic Hyperplasia.

Authors:  Priyanka Rai; Alok Srivastava; Ishwar R Dhayal; Sanjeet Singh
Journal:  Curr Urol       Date:  2017-12-30

6.  Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate.

Authors:  Chi-Hang Yee; Joseph Hon-Ming Wong; Peter Ka-Fung Chiu; Jeremy Yuen-Chun Teoh; Chi-Kwok Chan; Eddie Shu-Yin Chan; See-Ming Hou; Chi-Fai Ng
Journal:  Urol Ann       Date:  2016 Oct-Dec

7.  Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?

Authors:  Peng Xu; Abai Xu; Binshen Chen; Shaobo Zheng; Yawen Xu; Hulin Li; Haiyan Shen; Chunxiao Liu
Journal:  Asian J Urol       Date:  2017-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.